Department of Orthopaedic Surgery, Massachusetts General Hospital, 55 Fruit St, Boston, MA 02114, USA.
Department of Orthopaedic Surgery, Massachusetts General Hospital, 55 Fruit St, Boston, MA 02114, USA.
Spine J. 2018 Oct;18(10):1837-1844. doi: 10.1016/j.spinee.2018.03.023. Epub 2018 Apr 9.
Recurrence of spinal epidural abscess (SEA) after treatment is an important cause of continued morbidity for patients.
The purpose of this study was to identify independent predictors of recurrence of SEA.
STUDY DESIGN/SETTING: This was a retrospective, case-control study.
Patients 18 years or older with a diagnosis of SEA admitted to our hospital system during the study period were included in the study sample.
The outcome measure was recurrence of SEA, defined as a reaccumulation of pus or infected granulation tissue in the epidural space after initial treatment.
All patients older than 18 years admitted to our hospital system with a diagnosis of SEA from 1993 to 2016 were identified, and explanatory variables and outcomes were collected retrospectively. Patients 18 years or older diagnosed with SEA were included. We excluded patients whose treatment was initiated at an outside institution. Bivariate and multivariate analyses were performed to identify independent predictors of recurrence.
We identified 1,053 patients with SEA. We only considered patients to be recurrence-free if they had no documented recurrence with greater than 20 weeks of follow-up. Five hundred thirty-four patients were recurrence-free and 38 had documented recurrence, yielding 572 patients who were included in this analysis. Bivariate and multivariate analyses identified three independent predictors of recurrence: history of intravenous drug use, fecal incontinence or retention, and local spinal wound infection.
Patients with SEA who have a history of intravenous drug use, bowel dysfunction at presentation, or concurrent local spinal wound infection are at increased risk of disease recurrence. These patients ought to be closely followed up after discharge, with frequent serial imaging and aggressive antibiotic treatment.
脊髓硬膜外脓肿(SEA)治疗后复发是患者持续发病的重要原因。
本研究旨在确定 SEA 复发的独立预测因素。
研究设计/设置:这是一项回顾性病例对照研究。
在研究期间,我院系统收治的年龄在 18 岁及以上的 SEA 诊断患者被纳入研究样本。
观察指标为 SEA 复发,定义为初始治疗后硬膜外间隙再次积聚脓液或感染性肉芽组织。
从 1993 年至 2016 年,我院系统收治的所有年龄大于 18 岁的 SEA 患者均被识别出来,并回顾性收集解释变量和结局。纳入年龄大于 18 岁的 SEA 患者。我们排除了在院外开始治疗的患者。进行了单变量和多变量分析,以确定复发的独立预测因素。
我们共识别出 1053 例 SEA 患者。只有在随访时间超过 20 周且无记录复发的情况下,我们才认为患者无复发。534 例患者无复发,38 例有记录复发,共有 572 例患者纳入本分析。单变量和多变量分析确定了复发的三个独立预测因素:静脉吸毒史、粪便失禁或潴留以及局部脊柱伤口感染。
有静脉吸毒史、就诊时存在肠功能障碍或同时存在局部脊柱伤口感染的 SEA 患者,疾病复发风险增加。这些患者在出院后应密切随访,进行频繁的连续影像学检查和积极的抗生素治疗。